Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients-Reference-Cited by-同舟云学术

Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients

Published:2013-12-20 Issue:3 Volume:46 Page:175-180
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Balandin Moreno B.,Fernández Simón I.,Pintado García V.,Sánchez Romero I.,Isidoro Fernández B.,Romera Ortega M. A.,Alcántara Carmona S.,Pérez Redondo M.,Galdos Anuncibay P.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365548.2013.861608

Reference30 articles.

1. Tigecycline: an update

2. Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials

3. Efficacy and safety of tigecycline: a systematic review and meta-analysis

4. Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

5. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors analysis of hypofibrinogenemia associated with tigecycline;2024-03-18

2. Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis;Microbial Pathogenesis;2023-06

3. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms;Journal of Microbiology, Immunology and Infection;2022-06

4. Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-11-04

5. Ceftazidime–Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients;Infectious Diseases and Therapy;2021-10-15